phosphoserine has been researched along with Hypertrophy in 8 studies
Phosphoserine: The phosphoric acid ester of serine.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We reported that clenbuterol (CB) induced masseter muscle hypertrophy and slow-to-fast myosin heavy chain (MHC) isoform transition through direct muscle β2-adrenergic receptor stimulation." | 3.81 | Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. ( Fujita, T; Mototani, Y; Nakamura, Y; Ohnuki, Y; Okumura, S; Saeki, Y; Shiozawa, K; Suita, K; Umeki, D, 2015) |
| " These results demonstrate that the effects of formoterol are mediated, in part, through the activation of Akt-mTOR pathway and that other signaling pathways become more important in the regulation of skeletal muscle mass with chronic administration of β2-agonists." | 1.39 | Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle. ( Amirouche, A; Berthon, P; Castells, J; Desgeorges, MM; Durieux, AC; Freyssenet, DG; Gallot, YS; Joassard, OR, 2013) |
| "Vascular fibrosis is a major complication of hypertension and atherosclerosis, yet it is largely untreatable." | 1.35 | Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels. ( Arany, ZP; Hofmann, F; Itoh, H; Miyashita, K; Nakao, K; Sawada, N; Sone, M; Tsujimoto, H; Yamahara, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Stanford, SM | 1 |
| Collins, M | 1 |
| Diaz, MA | 1 |
| Holmes, ZJ | 1 |
| Gries, P | 1 |
| Bliss, MR | 1 |
| Lodi, A | 1 |
| Zhang, V | 1 |
| Tiziani, S | 1 |
| Bottini, N | 1 |
| Ranek, MJ | 1 |
| Kokkonen-Simon, KM | 1 |
| Chen, A | 1 |
| Dunkerly-Eyring, BL | 1 |
| Vera, MP | 1 |
| Oeing, CU | 1 |
| Patel, CH | 1 |
| Nakamura, T | 2 |
| Zhu, G | 1 |
| Bedja, D | 1 |
| Sasaki, M | 1 |
| Holewinski, RJ | 1 |
| Van Eyk, JE | 1 |
| Powell, JD | 1 |
| Lee, DI | 1 |
| Kass, DA | 1 |
| Joassard, OR | 1 |
| Amirouche, A | 1 |
| Gallot, YS | 1 |
| Desgeorges, MM | 1 |
| Castells, J | 1 |
| Durieux, AC | 1 |
| Berthon, P | 1 |
| Freyssenet, DG | 1 |
| Umeki, D | 1 |
| Ohnuki, Y | 1 |
| Mototani, Y | 1 |
| Shiozawa, K | 1 |
| Suita, K | 1 |
| Fujita, T | 1 |
| Nakamura, Y | 1 |
| Saeki, Y | 1 |
| Okumura, S | 1 |
| Sawada, N | 1 |
| Itoh, H | 1 |
| Miyashita, K | 1 |
| Tsujimoto, H | 1 |
| Sone, M | 1 |
| Yamahara, K | 1 |
| Arany, ZP | 1 |
| Hofmann, F | 1 |
| Nakao, K | 1 |
| Hardt, SE | 1 |
| Tomita, H | 1 |
| Katus, HA | 1 |
| Sadoshima, J | 1 |
| Mao, K | 1 |
| Kobayashi, S | 1 |
| Jaffer, ZM | 1 |
| Huang, Y | 1 |
| Volden, P | 1 |
| Chernoff, J | 1 |
| Liang, Q | 1 |
| Hosooka, T | 1 |
| Noguchi, T | 1 |
| Kotani, K | 1 |
| Sakaue, H | 1 |
| Inoue, H | 1 |
| Ogawa, W | 1 |
| Tobimatsu, K | 1 |
| Takazawa, K | 1 |
| Sakai, M | 1 |
| Matsuki, Y | 1 |
| Hiramatsu, R | 1 |
| Yasuda, T | 1 |
| Lazar, MA | 1 |
| Yamanashi, Y | 1 |
| Kasuga, M | 1 |
8 other studies available for phosphoserine and Hypertrophy
| Article | Year |
|---|---|
The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Cell Differentiation; Cell Respiration; Cell Size; | 2021 |
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Topics: Animals; Autophagy; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Disease Progression; Enzy | 2019 |
Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Topics: Animals; Autophagy; Cyclic AMP Response Element-Binding Protein; Ethanolamines; Extracellular Signal | 2013 |
Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Topics: Administration, Oral; Animals; Body Weight; Clenbuterol; Dexamethasone; Energy Metabolism; Feeding B | 2015 |
Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels.
Topics: Angiotensin II; Animals; Blood Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Act | 2009 |
Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Topics: Adenoviridae; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atri | 2004 |
Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.
Topics: Animals; Cell Survival; Cells, Cultured; Enzyme Activation; Gene Silencing; Gene Targeting; Humans; | 2008 |
Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, White; Adiposity; Animals; Diet; DNA-Binding Proteins; Ext | 2008 |